Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GRANITE: Airsupra Effectiveness in the Real World A Retrospective Prevalent New-user Cohort Study to Describe Characteristics and Compare Effectiveness of Airsupra vs Albuterol, in Patients With Asthma Requiring Use of Rescue Therapy in a Real-world Setting in the United States

NCT07141277 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07141277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07141277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GRANITE: Airsupra Effectiveness in the Real World A Retrospective Prevalent New-user Cohort Study to Describe Characteristics and Compare Effectiveness of Airsupra vs Albuterol, in Patients With Asthma Requiring Use of Rescue Therapy in a Real-world Setting in the United States
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 9, 2025
Completion date
March 20, 2026
Enrollment
4,060 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma